Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
New York Appeals Court Upholds Dismissal of Mirena MDL
The U.S. Court of Appeals for the Second Circuit has upheld the summary judgment dismissal of the multidistrict lawsuit (MDL) against the maker of the intrauterine birth control device Mirena after finding that none of the experts proffered by the nearly 1,300 plaintiffs were reliable. Mirena MDL v. Bayer Healthcare Pharmaceuticals Inc., 2017 U.S. App. LEXIS 20875 (2nd Cir. 10/24/17).
Plaintiffs all claimed they were injured by the implantable intrauterine birth control device marketed by Bayer under the name Mirena. All parties agreed that it was possible for a user's uterus to be injured during the insertion of the device, but the plaintiffs claimed that their injuries did not occur at insertion but later on, because the device migrated and perforated their uteri.
The plaintiffs presented three expert witnesses to back up their claims that the device migrated after insertion, but the U.S. District Court for the Southern District of New York found all three unreliable. Specifically, District Court Judge Cathy Siebel found that none of the experts had done any research on the question of Mirena device migration prior to being hired by the plaintiffs, and all assumed that the women's explanation of the cause of their injuries was valid. According to Judge Siebel, the plaintiffs' experts accepted this explanation, then “worked backwards to hypothesize a mechanism by which it might occur.”
The Second Circuit panel, made up of Judges John Walker Jr., Jose Cabranes and Reena Raggi, affirmed after finding that the expert testimony offered did not meet the test for admissibility found in Daubert v. Merrell Dow Pharmaceuticals. One of the criteria in Daubert — that the expert's theory is one that had been accepted by the relevant scientific community — seemed particularly troubling to the appeals court, as it was shown that the obstetrics and gynecological community has not accepted that the “secondary perforation” the plaintiffs claimed is something that actually occurs. On this point, the court concluded that “[n]ot only do the experts fail to identify any authorities that directly support the existence of secondary perforation, but what scientific authority there is casts doubt on the phenomenon's existence.”
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
In June 2024, the First Department decided Huguenot LLC v. Megalith Capital Group Fund I, L.P., which resolved a question of liability for a group of condominium apartment buyers and in so doing, touched on a wide range of issues about how contracts can obligate purchasers of real property.
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
Latham & Watkins helped the largest U.S. commercial real estate research company prevail in a breach-of-contract dispute in District of Columbia federal court.
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.